This study retrospectively assess the effect or using balanced hydroxyethyl sctarch (HES) 130/0.4 or a balanced crystalloid solution as a pump prime and for intraoperative fluid therapy on the risk of early acute postoperative kidney injury in adult cardiac surgery patients.
Study Type
OBSERVATIONAL
Enrollment
697
2500 mL of balanced HES 130/0.4
2500 mL of balanced crystalloid.
AKIN SCr
Stage of acute kidney injury using the Acute Kidney Injury Network Classification omitting the diuresis criteria.
Time frame: Forty eight hours
AKIN SCr+UO
Stage of acute kidney injury using the Acute Kidney Injury Network Classification including the diuresis criteria.
Time frame: Forty eight hours
Postoperative dialysis
Requirement of postoperative renal replacement therapy
Time frame: 30 days
Respiratory complication
Need for reintubation, non-invasive ventilation or prolonged intensive care unit stay as a consequence of atelectasis, pulmonary edema or pneumonia.
Time frame: 30 days
ICU stay
Length of stay at the intensive care unit
Time frame: 30 days
Hospital stay
Length of stay at the hospital
Time frame: 30 days
30-day mortality
Death in hospital or within 30 days of surgery
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.